Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.

Colovic, Natasa

Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma. [electronic resource] - Archives of dermatological research Oct 2009 - 689-92 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

1432-069X

10.1007/s00403-009-0967-1 doi


Adult
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Murine-Derived
Antigens, Neoplasm--metabolism
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Humans
Immunotherapy
Injections, Intravenous
Lymphoma, Large B-Cell, Diffuse--diagnosis
Male
Prednisone--therapeutic use
Proto-Oncogene Proteins c-bcl-2--metabolism
Rituximab
Skin Neoplasms--diagnosis
Treatment Outcome
Vesicular Transport Proteins--metabolism
Vincristine--therapeutic use